UK markets closed

Novo Nordisk A/S (NVO)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
139.17-0.42 (-0.30%)
As of 02:55PM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 309.35B
Enterprise value 309.67B
Trailing P/E 38.98
Forward P/E 31.25
PEG ratio (5-yr expected) 2.03
Price/sales (ttm)12.23
Price/book (mrq)25.66
Enterprise value/revenue 1.75
Enterprise value/EBITDA 4.03

Trading information

Stock price history

Beta (5Y monthly) 0.33
52-week change 331.79%
S&P500 52-week change 3-9.23%
52-week high 3144.78
52-week low 394.75
50-day moving average 3133.60
200-day moving average 3114.66

Share statistics

Avg vol (3-month) 31.43M
Avg vol (10-day) 31.79M
Shares outstanding 52.25B
Implied shares outstanding 6N/A
Float 81.61B
% held by insiders 10.01%
% held by institutions 18.22%
Shares short (12 Jan 2023) 41.65M
Short ratio (12 Jan 2023) 41.14
Short % of float (12 Jan 2023) 4N/A
Short % of shares outstanding (12 Jan 2023) 40.07%
Shares short (prior month 14 Dec 2022) 41.37M

Dividends & splits

Forward annual dividend rate 41.77
Forward annual dividend yield 41.28%
Trailing annual dividend rate 312.40
Trailing annual dividend yield 38.88%
5-year average dividend yield 42.00
Payout ratio 445.42%
Dividend date 303 Apr 2023
Ex-dividend date 423 Mar 2023
Last split factor 25:1
Last split date 308 Jan 2014

Financial highlights

Currency in DKK.

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Dec 2022


Profit margin 31.38%
Operating margin (ttm)42.73%

Management effectiveness

Return on assets (ttm)21.69%
Return on equity (ttm)72.00%

Income statement

Revenue (ttm)176.95B
Revenue per share (ttm)78.11
Quarterly revenue growth (yoy)25.50%
Gross profit (ttm)148.51B
Net income avi to common (ttm)55.52B
Diluted EPS (ttm)3.54
Quarterly earnings growth (yoy)24.80%

Balance sheet

Total cash (mrq)23.57B
Total cash per share (mrq)10.48
Total debt (mrq)25.78B
Total debt/equity (mrq)30.88
Current ratio (mrq)0.89
Book value per share (mrq)37.10

Cash flow statement

Operating cash flow (ttm)78.89B
Levered free cash flow (ttm)57.5B